Position in RPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,206,553,046
+$191,391,067 QoQ
Shares Held
25,152,242
-4.3% QoQ
Ownership
4.37%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 75%
Shared 0%
None 25%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. RPRX ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
This page
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in RPRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,206,553,046 | 25,152,242 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,015,161,979 | 26,272,308 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $987,371,267 | 27,986,714 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,454,092,286 | 40,357,821 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,226,649,412 | 39,404,093 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $672,936,781 | 26,379,333 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $789,012,142 | 27,890,143 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $735,372,302 | 27,886,701 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,021,471,137 | 33,634,216 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $887,192,563 | 31,583,929 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $825,793,446 | 30,427,172 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,041,601,843 | 33,884,250 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,440,627,696 | 39,984,116 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $1,743,241,622 | 44,110,365 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,726,047,615 | 42,957,880 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,511,478,999 | 35,953,354 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,098,873,070 | 28,205,161 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $879,879,828 | 22,079,795 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $690,626,615 | 19,109,757 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $987,692,128 | 24,095,929 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,219,302,007 | 27,952,820 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,248,374,525 | 24,942,548 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $765,181,947 | 18,188,304 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $794,107,636 | 16,356,491 | Shares | Defined | 2020-08-24 | |
| No filing history on record for this holder in this stock. | ||||||